Genovis AB’s (publ) Chief Financial Officer (CFO) Johny Humaloja has resigned from his position to take on new challenges. Johny has been employed by Genovis since 2019 and he will continue in his current role during the notice period. A process to recruit a new CFO will be initiated immediately. “During his time at Genovis, […]
This certification further demonstrates NEB’s commitment to environmental stewardship, scientific advancement and social responsibility as a global life science leader. IPSWICH, MA — New England Biolabs (NEB®), a leader in the discovery and production of enzymes for molecular biology applications, today announced it has become a Certified B Corporation™ (B Corp™), joining a global community […]
Three new bio-layer interferometry (BLI) systems: Octet® R2 with 2-channels, Octet® R4 with 4-channels and Octet® R8 with 8-channels Field upgradeable to the higher channel system, providing the flexibility to expand based on throughput needs and budget Rapidly determine affinity, kinetics, and specificity of protein-protein and protein-small molecule interactions as well as measure protein concentrations in crude samples. […]
Transaction combines SomaLogic’s comprehensive proteomics technology platform with CM Life Sciences II, a leading life science-focused SPAC, led by affiliates of institutional investors Casdin Capital and Corvex Management. Combination is expected to provide up to $651 million in cash proceeds for SomaLogic, expanding the cash on its balance sheet to $686 million to catalyze organic […]
For the efficient monitoring of aflatoxin contamination, it is necessary to apply analytical kits capable to detect all the four aflatoxins B1, B2, G1 and G2, in an accurate and preferably fast manner. H2AFLA is a new rapid ELISA kit for the detection of total aflatoxins B and G in different types of matrices. The […]
UPPSALA, Sweden — Olink Holding AB (publ) (Nasdaq: OLK) (“Olink” or the “Company”), today announced the pricing of its initial public offering of 17,647,058 common shares in the form of American Depositary Shares (“ADSs”), including 4,411,764 ADSs to be sold by the selling shareholders, at a price to the public of $20.00 per ADS, with […]
NEW YORK — Avista Capital Partners (“Avista”), a leading private equity firm focused exclusively on healthcare, today announced that it has signed a definitive agreement to invest in eMolecules (“eMolecules,” or the “Company”), a novel and fast-growing e-procurement platform for high-value chemicals and bioreagents used by the leading pharmaceutical companies in drug discovery. Financial terms […]
ROCHESTER, Minn. ― Mayo Clinic and Thermo Fisher Scientific have joined forces to bring innovative solutions to patients by accelerating clinical validation, and commercialization of selected next-generation sequencing (NGS), mass spectrometry and immunology diagnostic tools. The Advanced Diagnostics Laboratory in One Discovery Square, which is part of the Destination Medical Center initiative, will be the home […]
SOUTH SAN FRANCISCO, Calif. & LA JOLLA, Calif. — Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that it signed a partnership agreement with Kyowa Kirin Pharmaceutical Research, Inc., a subsidiary of Kyowa Kirin Co., Ltd. (Kyowa Kirin, TSE: […]
NanoTemper Technologies and PharmAI combine competencies to develop biophysical tools that remove costly and time-consuming guesswork from large datasets NanoTemper Technologies announced a partnership with PharmAI, the Dresden-based start-up that specializes in virtual screening software. Together, they will zero in on one of the biggest roadblocks to quick drug development: Researchers have to comb through […]
Pay Invoice
Latest Blogs
-
Automation Provides a Boost for Sample Prep Instrument Market Growth
August 25, 2026 11:49 am
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
